Global Oligonucleotide Therapeutics Market – Industry Trends and Forecast to 2029

Data0066

51
views

Global Oligonucleotide Therapeutics Market – Industry Trends and Forecast to 2029

Global Oligonucleotide Therapeutics Market was valued at USD 18.19 billion in 2021 and is expected to reach USD 51.35 billion by 2029, registering a CAGR of 13.85% during the forecast period of 2022-2029. “Infectious Diseases” is expected to witness high growth owing to increase in the number of infectious diseases, such as COVID-19. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework

Oligonucleotides refer to the short chain RNA or DNA that are generally manufactured by making the use of automated synthesizers. Anion exchange chromatography which is followed by desalting and freezing technique is done for the purification of the oligonucleotide.

Get the sample copy of Report her https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oligonucleotide-therapeutics-market

Global Oligonucleotide Therapeutics Market Scope and Market Size

Type

· Antisense
· Ribozymes
· Aptamers
· Mirna
· Cpg/Immunostimulatory
· RNAi

Based on type, the oligonucleotide therapeutics market is segmented into antisense, ribozymes, aptamers, miRNA, CpG/Immunostimulatory and RNAi.

Application

· Infectious Diseases
· Oncology
· Neurodegenerative Disorders
· Cardiovascular Diseases
· Kidney Diseases
· Others

Based on application, the oligonucleotide therapeutics market is segmented into infectious diseases, oncology, neurodegenerative disorders, cardiovascular diseases, kidney diseases and others.

Oligonucleotide Therapeutics Market Regional Analysis/Insights

The countries covered in the oligonucleotide therapeutics market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South Amer

Competitive Landscape and Oligonucleotide Therapeutics Market Share Analysis

Some of the major players operating in the oligonucleotide therapeutics market are

· PCI Biotech Holding (Norway)

· SomaGenics Inc (US)
· Hepion Pharmaceuticals (US)
· Alnylam Pharmaceuticals (US)
· Regulus Therapeutics Inc (US)
· Ionis Pharmaceuticals (US)
· Gilead Sciences, Inc (US)
· Santaris (Denmark)
· InteRNA Technologies B.V. (Netherlands)
· Mirage (US), Biogen (US)
· Merck KgaA (Germany)
· Pfizer Inc. (US)

Get Full Access Of Report https://www.databridgemarketresearch.com/reports/global-oligonucleotide-therapeutics-market

MAJOR TOC OF THE REPORT

Ø INTRODUCTION
Ø MARKET SEGMENTATION
Ø EXECUTIVE SUMMARY
Ø PREMIUM INSIGHTS
Ø MARKET OVERVIEW
Ø MARKET, COMPANY LANDSCAPE
Ø SWOT ANALYSIS
Ø COMPANY PROFILE
Ø QUESTIONNAIRE

RELATED REPORTS

Get TOC Details https://www.databridgemarketresearch.com/toc/?dbmr=global-oligonucleotide-therapeutics-market

About Us-:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market

Contact-:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com

Global Oligonucleotide Therapeutics Market

Global Oligonucleotide Therapeutics Market – Industry Trends and Forecast to 2029